Market By Product, Application, And Geography | Forecast 2019-2028
According to Triton, the opioid drugs market in Latin America is expected to proliferate with a CAGR of 2.79% in the forecast period of 2019-2028.
Report scope can be customized per your requirements. Request For Customization
The countries reviewed in this market are:
•          Brazil
•          Mexico
•          Rest of Latin America
with a population of around 639 million people, Latin America is a diverse region. Countries in the region encounter numerous public health challenges while helping patients dealing with different forms of moderate to severe pain. The percentage of opioid consumption varies from country to country; however, it ranges from low to moderate, as per the international standards. A significant rise in opioid analgesics consumption has been observed in several countries of Latin America. This is majorly boosting the studied market growth.
However, it is important to note that the cost of preparing most commercial opioids is much higher in Latin America as compared to North America and Europe. In recent years, health authorities have warned that drug abuse has become a growing problem in the region. The Latin American Commission on Drugs and Democracy has, therefore, recommended addressing drug abuse as a serious health problem, and implement policies to reduce unnecessary opioid consumption.
The Brazilian Society for Study of Pain has put forth that, the rate of incidence of chronic pain in the country is around 30%, with non-cancer pain accounting for 60% to 70% of the pain cases. It is important to carefully monitor opioid treatment for patients. However, this treatment is generally reserved for refractory cases. Thus, around 10% of the patients suffering from chronic pain eventually receive opioid treatment. The rate of incidence of chronic pain in cancer patients is 63%. Opioid drugs have a major role to play in treating patients with chronic pain. Codeine is generally prescribed more often for treating mild-to-moderate pain. However, oxycodone has witnessed the largest increase in use. Along with these, fentanyl is also being widely consumed. This suggests a trend of use of extremely potent opiates in Brazil.
Purdue Pharma LP is a manufacturer of pharmaceutical products. The company is engaged in the R&D, production, and marketing of prescription and OTC medicines and healthcare products. Butrans® (buprenorphine) Transdermal System CIII, Hysingla® ER (hydrocodone bitartrate) extended-release tablets CII, and OxyContin® (oxycodone HCl) extended-release tablets CII are some of its opioid products. The company has a vast geographical reach, with a notable presence in Latin America.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT
1.   LATIN AMERICA OPIOID DRUGS MARKET - SUMMARY
2.   INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. KEY INSIGHTS
2.2.1. TECHNOLOGICAL ADVANCEMENTS TO FIGHT AGAINST OPIOID DRUG CRISIS
2.2.2. DIFFERENT SOURCES OF PROCURING OPIOIDS
2.3. PORTER’S FIVE FORCE ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTE
2.3.3. BARGAINING POWER OF SUPPLIERS
2.3.4. BARGAINING POWER OF BUYERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. MARKET ATTRACTIVENESS INDEX
2.5. VENDOR SCORECARD
2.6. MARKET DRIVERS
2.6.1. GROWTH IN MEDICAL CASES & RISING PREVALENCE OF CANCER
2.6.2. INCREASE IN THE USE OF ABUSE-DETERRENT FORMULATIONS TO RESTRICT THE RISE OF OPIOID DEPENDENCE
2.6.3. DEMAND FOR PALLIATIVE THERAPY
2.7. MARKET RESTRAINTS
2.7.1. GOVERNMENT RULES AND REGULATIONS
2.7.2. INCREASED NUMBER OF LAWSUITS AGAINST THE MANUFACTURERS OF OPIOID DRUGS
2.7.3. USAGE OF OPIOIDS FOR NON-MEDICAL PURPOSES
2.8. MARKET OPPORTUNITIES
2.8.1. RISING COMMERCIAL SUCCESS AND MARKET SHARE OF OPIOID DRUGS
2.8.2. GROWTH OF INVESTMENTS IN RESEARCH OF PHARMACEUTICAL USES OF OPIOIDS
2.9. MARKET CHALLENGES
2.9.1. OPIOID EPIDEMIC SPREADING
2.9.2. RISING DEATH RATE DUE TO OPIOID OVERDOSE
2.10. COVID-19 IMPACT ON THE OPIOID DRUGS MARKET
3.   LATIN AMERICA OPIOID DRUGS MARKET OUTLOOK - BY PRODUCT
3.1. BUPRENORPHINE
3.2. FENTANYL
3.3. HYDROCODONE
3.4. MORPHINE
3.5. OXYCODONE
3.6. TRAMADOL
3.7. OTHER PRODUCTS
4.   LATIN AMERICA OPIOID DRUGSS MARKET OUTLOOK - BY APPLICATION
4.1. PAIN RELIEF
4.1.1. CANCER PAIN
4.1.2. POSTOPERATIVE PAIN MANAGEMENT
4.1.3. LOWER BACK PAIN
4.1.4. ORTHOPEDIC
4.1.5. NEUROPATHIC
4.1.6. FIBROMYALGIA
4.2. ANESTHESIA
4.3. COUGH SUPPRESSION
4.4. DIARRHEA SUPPRESSION
4.5. DE-ADDICTION
5.   LATIN AMERICA OPIOID DRUGS MARKET – REGIONAL OUTLOOK
5.1. BRAZIL
5.2. MEXICO
5.3. REST OF LATIN AMERICA
6.   COMPETITIVE LANDSCAPE
6.1. ACURA PHARMACEUTICALS
6.2. BIODELIVERY SCIENCES INTERNATIONAL INC
6.3. CIPHER PHARMACEUTICALS INC
6.4. ALLERGAN (ACQUIRED BY ABBVIE)
6.5. COLLEGIUM PHARMACEUTICAL INC
6.6. DAIICHI SANKYO
6.7. HIKMA PHARMACEUTICALS PLC
6.8. INDIVIOR INC
6.9. JANSSEN PHARMACEUTICALS INC
6.10. JOHNSON JOHNSON
6.11. LANNETT CO INC
6.12. LUPIN LTD
6.13. MYLAN NV
6.14. PFIZER INC
6.15. PURDUE PHARMA LP
6.16. SANOFI-AVENTIS SA
6.17. SUN PHARMACEUTICAL INDUSTRIES LTD
6.18. TEVA PHARMACEUTICAL INDUSTRIES LTD
7.   METHODOLOGY & SCOPE
7.1. RESEARCH SCOPE & DELIVERABLES
7.2. SOURCES OF DATA
7.3. RESEARCH METHODOLOGY
TABLE 1: LATIN AMERICA OPIOID DRUGS MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: LATIN AMERICA OPIOID DRUGS MARKET, BY PRODUCT, 2019-2028 (IN $ MILLION)
TABLE 4: LATIN AMERICA OPIOID DRUGS MARKET, BY APPLICATION, 2019-2028 (IN $ MILLION)
TABLE 5: LATIN AMERICA OPIOID DRUGS MARKET, BY PAIN RELIEF, 2019-2028 (IN $ MILLION)
TABLE 6: LATIN AMERICA OPIOID DRUGS MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
FIGURE 1: PORTER’S FIVE FORCE ANALYSIS
FIGURE 2: MARKET ATTRACTIVENESS INDEX
FIGURE 3: LATIN AMERICA OPIOID DRUGS MARKET, BY BUPRENORPHINE, 2019-2028 (IN $ MILLION)
FIGURE 4: LATIN AMERICA OPIOID DRUGS MARKET, BY FENTANYL, 2019-2028 (IN $ MILLION)
FIGURE 5: LATIN AMERICA OPIOID DRUGS MARKET, BY HYDROCODONE, 2019-2028 (IN $ MILLION)
FIGURE 6: LATIN AMERICA OPIOID DRUGS MARKET, BY MORPHINE, 2019-2028 (IN $ MILLION)
FIGURE 7: LATIN AMERICA OPIOID DRUGS MARKET, BY OXYCODONE, 2019-2028 (IN $ MILLION)
FIGURE 8: LATIN AMERICA OPIOID DRUGS MARKET, BY TRAMADOL, 2019-2028 (IN $ MILLION)
FIGURE 9: LATIN AMERICA OPIOID DRUGS MARKET, BY OTHER PRODUCTS, 2019-2028 (IN $ MILLION)
FIGURE 10: LATIN AMERICA OPIOID DRUGS MARKET, BY PAIN RELIEF, 2019-2028 (IN $ MILLION)
FIGURE 11: LATIN AMERICA OPIOID DRUGS MARKET, BY CANCER PAIN, 2019-2028 (IN $ MILLION)
FIGURE 12: LATIN AMERICA OPIOID DRUGS MARKET, BY POSTOPERATIVE PAIN MANAGEMENT, 2019-2028 (IN $ MILLION)
FIGURE 13: LATIN AMERICA OPIOID DRUGS MARKET, BY LOWER BACK PAIN, 2019-2028 (IN $ MILLION)
FIGURE 14: LATIN AMERICA OPIOID DRUGS MARKET, BY ORTHOPEDIC, 2019-2028 (IN $ MILLION)
FIGURE 15: LATIN AMERICA OPIOID DRUGS MARKET, BY NEUROPATHIC, 2019-2028 (IN $ MILLION)
FIGURE 16: LATIN AMERICA OPIOID DRUGS MARKET, BY FIBROMYALGIA, 2019-2028 (IN $ MILLION)
FIGURE 17: LATIN AMERICA OPIOID DRUGS MARKET, BY ANESTHESIA, 2019-2028 (IN $ MILLION)
FIGURE 18: LATIN AMERICA OPIOID DRUGS MARKET, BY COUGH SUPPRESSION, 2019-2028 (IN $ MILLION)
FIGURE 19: LATIN AMERICA OPIOID DRUGS MARKET, BY DIARRHEA SUPPRESSION 2019-2028 (IN $ MILLION)
FIGURE 20: LATIN AMERICA OPIOID DRUGS MARKET, BY DE-ADDICTION, 2019-2028 (IN $ MILLION)
FIGURE 21: LATIN AMERICA OPIOID DRUGS MARKET; REGIONAL OUTLOOK 2019 & 2028 (IN %)
FIGURE 22: BRAZIL OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 23: MEXICO OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 24: REST OF LATIN AMERICA OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)